Anti Viral Agents and Treatments

The Universal Therapeutic Industry at a predicted worth of $1485.02 million in 2013 is expected to reach $1932.8 million by 2018 growing at a CAGR of 5.6%.

Virotherapy is a sub-field of Virology and therapeutics, which uses biotechnology as a means to convert viruses into required therapeutic agents by reprogramming the genome and other metabolic pathways of viruses to treat diseases. There are 3 categories of virotherapy as of now:
1. Anti-cancer oncolytic viruses, 
2. Viral vectors for gene therapy and
3. Viral immunotherapy.

  • Categories in Virotherapy
  • Required therapeutic agents
  • Viral vectors for gene therapy
  • Newly developed therapies for various viruses

Related Conference of Anti Viral Agents and Treatments

October 26-28, 2017

8th Clinical Microbiology Conference

Paris, France
November 29-December 01, 2017

4th World Congress and Expo on Applied Microbiology

Madrid, Spain
July 02-04, 2018

10th International Virology Congress and Expo

Vienna, Austria
February 22-23, 2018

8th Global Summit on Microbiology & Infectious Diseases

Paris, France
June 28-29, 2018

11th Annual Medical Microbiology Summit & Expo

Amsterdam, Netherlands
July 11-12, 2018

2nd International Conference on Microbial Ecology & Eco Systems

Toronto, Ontario, Canada
(10 Plenary Forums 2 days 1 event)
July 11-12, 2018

7th International conference on Environmental Microbiology & Soil Microbiology

Toronto, Ontario, Canada
(10 Plenary Forums 2 days 1 event)
July 16-18, 2018 London, UK

Microbialphysiology 2018

September 10-11, 2018

47th World Congress on Microbiology

London, UK
(9 Plenary forums, 2 days, 1 event)
December 05-06, 2018

8th Annual Congress on Clinical Microbiology

Toronto, Ontario, Canada

Anti Viral Agents and Treatments Conference Speakers

Recommended Sessions

Related Journals

Are you interested in